CLAIM CARD
The evidence base for colchicine's effects on inflammaging-related outcomes is populated predominantly by meta-analyses and secondary analyses of large cardiovascular trials. Additional systematic reviews by Razavi 2022 and Wang 2025 synthesized evidence across clinical trials of colchicine administered after acute coronary syndrome.
Evidence grade: exploratory
Contradiction status: none
Publication: 873ff54a-3a1e-4c35-b4ff-b2bb5ab68649
Provenance: Derivation Web chain
Citation Support
source_1Mohammadnia 2025source_2Li 2025source_3Ammirati 2026source_4Pascart 2026source_5Broekhoven 2022